期刊文献+

短发夹RNA沉默促肝细胞再生磷酸酶-3基因表达对乳腺癌MCF-7细胞生长和侵袭能力的影响 被引量:1

Effect of shRNA silencing PRL-3 gene expression on the growth and invasiveness of breast cancer MCF-7 cells
原文传递
导出
摘要 目的构建以促肝细胞再生磷酸酶-3(PRL-3)为靶基因的短发夹状小干扰RNA(short hairpin RNA,shRNA)表达载体,并探讨PRL-3-shRNA表达载体对人乳腺癌MCF-7细胞增殖、凋亡和侵袭能力的影响。方法 构建PRL-3基因特异性shRNA表达载体,使用脂质体法将PRL-3-shRNA表达载体转染入MCF-7细胞。采用Real-ti me PCR和Western blot分别检测转染后MCF-7细胞中PRL-3基因mRNA和蛋白的表达;运用四甲基偶氮唑蓝(methyl thiazolyl tetrazolium,MTT)比色法检测转染后MCF-7细胞的增殖水平,用流式细胞仪检测细胞凋亡的情况;采用Transwell小室法检测细胞侵袭力变化。计量资料采用单因素方差分析或重复测量方差分析。结果 酶切鉴定和测序分析证实PRL-3-shRNA表达载体成功构建。转染成功后,shRNA-1~3组PRL-3基因mRNA表达分别为(0.31±0.27)、(0.15±0.14)和(0.31±0.03),与空白组和阴性组(1.00±0.00、0.98±0.18)相比,差异有统计学意义(P〈0.05)。PRL-3-shRNA-2组PRL-3蛋白的表达量明显低于阴性组和空白组(0.50±0.02比0.91±0.03和0.89±0.02,P〈0.05);PRL-3-shRNA-2转染入MCF-7细胞后能明显降低其增殖水平(P〈0.05);PRL-3-shRNA-2组凋亡率明显高于空白组和阴性组[(8.37±1.85)%比(1.60±1.58)%和(0.16±0.05)%,P〈0.05];Transwell小室侵袭实验显示,PRL-3-shRNA-2组穿膜细胞数明显低于阴性组和空白组(P〈0.05)。结论 沉默PRL-3基因表达可抑制MCF-7细胞的增殖,促进凋亡。 Objective To study the effect of short hairpin RNA(shRNA)targeting phosphatase of regenerating liver-3(PRL-3)gene on the proliferation,apoptosis,and invasiveness of breast cancer MCF-7 cells.Methods The PRL-3 specific shRNA expression vector was constructed and confirmed by sequencing analysis.PRL-3-shRNA expression vector was transfected into MCF-7 cells via lipofectamineTM 2000.The expression level of mRNA and protein after transfection were determined by Real-time PCR and Western bolt respectively.Flow cytometry and MTT assay were performed to assess the effects of the PRL-3-shRNA on the proliferation and apoptosis of MCF-7 cells.Invasion capability of stably transfected MCF-7 cells was evaluated by transwell chamber model assay in vitro.Comparison between quantitative data was performed using one-way ANOVA or repeated measures ANOVA.Results PRL-3-shRNA expression vector was successfully constructed and transfected into MCF-7 cells.The PRL-3 mRNA levels in the groups of shRNA-1 ~3 were respectively reduced to(0.31±0.27),(0.15±0.14)and(0.31±0.03)after transfection,and were significantly lower than both the blank group(1.00±0.00)and the negative group(0.98±0.18);the difference was statistically significant(P0.05).The PRL-3 protein level in the group of shRNA-2(0.50±0.02)was also significantly lower than both the blank group(0.89±0.02)and the negative group(0.91±0.03),with statistically significant difference(P0.05).MTT results showed that the growth of MCF-7 cells after PRL-3-shRNA-2 transfection was decreased markedly(P0.05).The apoptotic rate in the PRL-3-shRNA-2 group(8.37±1.85%)was increased significantly compared with the blank group(1.60±1.58%)and the negative group(0.16±0.05%)(P0.05).Transwell chamber model assay showed that the trans-membrane cell numbers in the PRL-3-shRNA-2 group were greatly decreased compared with the blank group and the negative group(P0.05).Conclusions Silencing the expression of PRL-3 gene can effectively suppress the proliferation and invasion capability,and promote the apoptosis of MCF-7 cells.
出处 《中华乳腺病杂志(电子版)》 CAS 2011年第3期29-34,共6页 Chinese Journal of Breast Disease(Electronic Edition)
基金 广东省科技计划资助项目(2008B030301345)
关键词 乳腺肿瘤 促肝细胞再生磷酸酶-3 短发夹状小干扰RNA 基因治疗 breast neoplasms phosphatase of regenerating liver-3 shRNA gene therapy
  • 相关文献

参考文献3

二级参考文献49

  • 1O'Flynn EA,Morel JC,Gonzalez J,et al.Prediction of the presence of invasive disease from the measurement of extent of malignant microcalcification on mammography and ductal carcinoma in situ grade at core biopsy.Oin Radiol,2009,64:178-183.
  • 2Meijnen P,Peterse JL,Antonini N,et al.Immunohistochemicalcategorisation of ductal carcinoma in situ of the breast.British J Cancer,2008,98:137-142.
  • 3Bryan BB,Schnitt SJ,Collins LC,et al.Ductal carcinomain situ with besal-iike phenotype,a possible precursor to invasive basallike breast cancer.Mod Pathol,2006,19:617-621.
  • 4Steinman S,Wang J,Bourne P,et al.Expression of cytokeratin markers,ER-alpha,PR,HER-2/neu,and EGFR in pure ductal carcinoma in aim(DCIS)and DCIS with co-existing invesive ductal carcinoma(IDC)ofthe breast.Ann Clin Lab Sci,2007,37:127-134.
  • 5Tsikitis VL,Chung MA.Biology of ductal carcinoma in situ classification based on biologic potential.Am J Clln Oncol,2006,29:305-310.
  • 6Tavaesoli FA,Eusebi V.AFIP Atlas of tumor pathology.series 4 (Tumors of the mammary gland).Washington,DC:American Registry of Pathology and Armed Force Institute of Pathology,2009:54-71.
  • 7Gao Y,Niu Y,Wang X,et al.Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridization.J Mol Med,2009,87:145-152.
  • 8Alexe G,Dalgin GS,Scanfeld D,et al.Breast cancer stratification from analysis of micro-array data of micro-dissected specimens.Genome Inform,2007,18:130-140.
  • 9Daigin GS,Alexe G,Scanfeld D,et al.Portraits of brenst cancer progression.BMC Bioinformatics,2007,8:291.
  • 10Sinn HP.Breast cancer precursors:lessons learned from molecular genetics.J Mol Med,2009,87:113-115.

共引文献9

同被引文献9

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部